Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG

Matthias Blaickner; Peter Kindl

Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG

Matthias Blaickner, Peter Kindl

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	767-782
Seitenumfang	16
Fachzeitschrift	Cancer Biotherapy & Radiopharmaceuticals
Volume	23
Issue	6
Publikationsstatus	Veröffentlicht - 2008

Research Field

Nicht definiert

Diese Publikation zitieren

@article{bab7c959b34842739fc4e5140a9224ba,

title = "Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG",

author = "Matthias Blaickner and Peter Kindl",

note = "Mail Mitterecker",

year = "2008",

language = "English",

volume = "23",

pages = "767--782",

number = "6",

}

Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG. / Blaickner, Matthias; Kindl, Peter.
in: Cancer Biotherapy & Radiopharmaceuticals, Vol. 23, Nr. 6, 2008, S. 767-782.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG

AU - Blaickner, Matthias

AU - Kindl, Peter

N1 - Mail Mitterecker

PY - 2008

Y1 - 2008

M3 - Article

VL - 23

SP - 767

EP - 782

JO - Cancer Biotherapy & Radiopharmaceuticals

JF - Cancer Biotherapy & Radiopharmaceuticals

IS - 6

ER -